What is the address of DR. R. VAN LANDEGHEM?

The registered office of DR. R. VAN LANDEGHEM is located at Merodestraat(KIE) 78, 9130 Beveren-Kruibeke-Zwijndrecht.

Is DR. R. VAN LANDEGHEM still active?

Yes. According to the CBE (19 September 2026) DR. R. VAN LANDEGHEM is active, legal situation “Normale toestand”, started on 5 August 2021.

Is DR. R. VAN LANDEGHEM registered on Peppol?

Yes, DR. R. VAN LANDEGHEM is registered on the Peppol network with ID 0208:0772323304.

What is the enterprise number of DR. R. VAN LANDEGHEM?

The enterprise number of DR. R. VAN LANDEGHEM is BE0772323304.

When was DR. R. VAN LANDEGHEM founded?

DR. R. VAN LANDEGHEM was founded on 5 August 2021.

Who are the directors of DR. R. VAN LANDEGHEM?

According to the 2025 annual accounts, the directors of DR. R. VAN LANDEGHEM are: Ruben Van Landeghem, LISELORE Loverix.

Is DR. R. VAN LANDEGHEM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 August 2021; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR. R. VAN LANDEGHEM make in 2025?

DR. R. VAN LANDEGHEM posted a profit after taxes of € 409,379 in financial year 2025.

What is the revenue of DR. R. VAN LANDEGHEM?

As a small company, DR. R. VAN LANDEGHEM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 559,263.

DR. R. VAN LANDEGHEM (Private Limited) - BE0772323304

Dossier DR. R. VAN LANDEGHEM, printed on 19 September 2026 from databakkes.be/en/0772323304/dr-r-van-landeghem. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. R. VAN LANDEGHEM from Beveren-Kruibeke-Zwijndrecht, company number BE0772323304, closed financial year 2025 with a result of € 409,379 after tax. For that financial year DR. R. VAN LANDEGHEM recorded a gross margin of € 559,263 and equity of € 23,170. Compared with financial year 2024, the result moved from € 334,699 to € 409,379. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 23,170

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 409,379

▲ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 285,893

▲ € 221,002 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 407,148 paid out

99 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 33,441

▼ 36% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 19,456

▼ 38% vs 2024

€ 12,248 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 875

▲ 182% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 64,072

▲ 21% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 118,992 Gross margin 2022: € 118,992 First fiscal year in the series	€ 313,097 Gross margin 2023: € 313,097 ▲ 163% vs 2022 (€ 118,992) Favourable step	€ 455,101 Gross margin 2024: € 455,101 ▲ 45% vs 2023 (€ 313,097) Favourable step	€ 559,263 Gross margin 2025: € 559,263 ▲ 23% vs 2024 (€ 455,101) Favourable step	▲ 23%
Profit after taxes	€ 92,153 Profit after taxes 2022: € 92,153 First fiscal year in the series	€ 230,714 Profit after taxes 2023: € 230,714 ▲ 150% vs 2022 (€ 92,153) Favourable step	€ 334,699 Profit after taxes 2024: € 334,699 ▲ 45% vs 2023 (€ 230,714) Favourable step	€ 409,379 Profit after taxes 2025: € 409,379 ▲ 22% vs 2024 (€ 334,699) Favourable step	▲ 22%
Equity	€ 105,527 Equity 2022: € 105,527 First fiscal year in the series	€ 336,240 Equity 2023: € 336,240 ▲ 219% vs 2022 (€ 105,527) Favourable step	€ 20,939 Equity 2024: € 20,939 ▼ 94% vs 2023 (€ 336,240) Unfavourable step	€ 23,170 Equity 2025: € 23,170 ▲ 11% vs 2024 (€ 20,939) Favourable step	▲ 11%
Total debts	€ 69,466 Total debts 2022: € 69,466 First fiscal year in the series	€ 75,845 Total debts 2023: € 75,845 ▲ 9% vs 2022 (€ 69,466) Unfavourable step	€ 369,807 Total debts 2024: € 369,807 ▲ € 293,961 vs 2023 (€ 75,845) Unfavourable step	€ 441,107 Total debts 2025: € 441,107 ▲ 19% vs 2024 (€ 369,807) Unfavourable step	▲ 19%
Cash	€ 77,006 Cash 2022: € 77,006 First fiscal year in the series	€ 231,064 Cash 2023: € 231,064 ▲ 200% vs 2022 (€ 77,006) Favourable step	€ 64,891 Cash 2024: € 64,891 ▼ 72% vs 2023 (€ 231,064) Unfavourable step	€ 285,893 Cash 2025: € 285,893 ▲ € 221,002 vs 2024 (€ 64,891) Favourable step	▲ € 221,002
Retained profit	€ 102,527 Retained profit 2022: € 102,527 First fiscal year in the series	€ 333,240 Retained profit 2023: € 333,240 ▲ 225% vs 2022 (€ 102,527) Favourable step	€ 17,939 Retained profit 2024: € 17,939 ▼ 95% vs 2023 (€ 333,240) Unfavourable step	€ 20,170 Retained profit 2025: € 20,170 ▲ 12% vs 2024 (€ 17,939) Favourable step	▲ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 650,000 Dividend 2024: € 650,000 Unchanged (€ 0) Unchanged	€ 407,148 Dividend 2025: € 407,148 ▼ 37% vs 2024 (€ 650,000) Unchanged	▼ 37%
Bank debt	€ 55,376 Bank debt 2022: € 55,376 First fiscal year in the series	€ 43,538 Bank debt 2023: € 43,538 ▼ 21% vs 2022 (€ 55,376) Favourable step	€ 31,566 Bank debt 2024: € 31,566 ▼ 27% vs 2023 (€ 43,538) Favourable step	€ 19,456 Bank debt 2025: € 19,456 ▼ 38% vs 2024 (€ 31,566) Favourable step	▼ 38%
Balance sheet total	€ 174,993 Balance sheet total 2022: € 174,993 First fiscal year in the series	€ 412,086 Balance sheet total 2023: € 412,086 ▲ 135% vs 2022 (€ 174,993) Unchanged	€ 390,746 Balance sheet total 2024: € 390,746 ▼ 5% vs 2023 (€ 412,086) Unchanged	€ 464,277 Balance sheet total 2025: € 464,277 ▲ 19% vs 2024 (€ 390,746) Unchanged	▲ 19%

Key figures of DR. R. VAN LANDEGHEM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. R. VAN LANDEGHEM?

What happened at DR. R. VAN LANDEGHEM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: profit of € 409,379 (▲ 22% vs 2024). Source: NBB ↗
Aug 5, 2021 New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
Aug 5, 2021 Start of the company according to the CBE. KBO

In short

From € 92,153 profit in 2022 to € 409,379 profit in 2025.

Paid € 336,743 in corporate taxes since 2022.

Best year ever: 2025, with € 409,379 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. R. VAN LANDEGHEM? We notify you, reason included.

Follow DR. R. VAN LANDEGHEM

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ruben Van Landeghem

LISELORE Loverix

DR. R. VAN LANDEGHEM

Signifeye 1.2%

Behind DR. R. VAN LANDEGHEM are Ruben Van Landeghem and LISELORE Loverix. It owns 1.2% of Signifeye itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Ruben Van Landeghem

Director

LISELORE Loverix

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Merodestraat(KIE) 78

9130 Beveren-Kruibeke-Zwijndrecht

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Dr. L. Van Landeghem

€ 222,948 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0772.323.304
VAT number: BE 0772.323.304
Registered office: Merodestraat(KIE) 78, 9130 Beveren-Kruibeke-Zwijndrecht
Names & denominations: DR. R. VAN LANDEGHEM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 5 August 2021
Peppol: Active · Active since 24 Nov 2023

View on CBE Public ↗ Annual accounts (NBB) ↗